Multicare Health System

Multicare Health System was paid $162.25M by Medicaid between Jan 2018 and Dec 2024, across 792 billing codes. Its largest line is 96361, Intravenous infusion, hydration; each additional hour — 10% of everything it billed.

33Billing provider infoMULTICARE HEALTH SYSTEM
TACOMA, WA 98405

33aNPI1366556227assigned 08/18/2006

33bProvider typeCommunity/Behavioral Health Agency

28Total paid$162.25M

24GClaims6,854,549

24DCodes billed792

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Community/Behavioral Health Agency providers in Washington

Rank by total paid#1 of 176

Median peer was paid$340K

This provider vs. median477×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official ROBERTSON, WILLIAM controls 20+ related entities in our dataset. Read more

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	915,277	$23.16M
2019	860,384	$21.29M
2020	813,926	$18.41M
2021	991,911	$23.52M
2022	1,094,341	$26.37M
2023	1,137,676	$25.98M
2024incomplete	1,041,034	$23.52M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
96361	Intravenous infusion, hydration; each additional hour	10%	56,926	46,857	$16.64M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	7.6%	171,116	124,189	$12.35M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	7.1%	104,261	95,574	$11.54M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	6.2%	119,538	107,180	$10.05M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	4.7%	83,656	76,987	$7.65M
J9271	Injection, pembrolizumab, 1 mg	4.3%	1,644	1,180	$6.99M
74177	Computed tomography, abdomen and pelvis; with contrast material	3.5%	32,722	31,020	$5.72M
J2350	Injection, ocrelizumab, 1 mg	3.1%	455	409	$5.02M
77412		2.1%	7,217	813	$3.33M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.7%	27,245	20,702	$2.75M
70450	Computed tomography, head or brain; without contrast material	1.6%	19,622	18,484	$2.66M
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	1.6%	11,156	7,934	$2.66M

780 more codes

99282	Emergency department visit for the evaluation and management, low to moderate severity	1.6%	23,934	$2.57M
J2323	Injection, natalizumab, 1 mg	1.5%	1,615	$2.38M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	1.4%	20,107	$2.23M
77386		1.3%	5,805	$2.07M
59025	Fetal non-stress test	1.1%	11,165	$1.74M
80053	Comprehensive metabolic panel	1.0%	339,690	$1.66M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	21,520	$1.60M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	62,496	$1.52M
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	47,565	$1.46M
J9263	Injection, oxaliplatin, 0.5 mg	<1%	1,906	$1.44M
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	762	$1.39M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	15,311	$1.34M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	98,097	$1.32M
96415		<1%	6,814	$1.21M
36415	Collection of venous blood by venipuncture	<1%	439,423	$1.15M
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	6,484	$1.14M
J9035	Injection, bevacizumab, 10 mg	<1%	728	$1.06M
71275	Computed tomographic angiography, chest, with contrast material	<1%	7,086	$1.04M
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	21,388	$988K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	98,111	$940K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	385,163	$887K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	3,997	$860K
84443	Thyroid stimulating hormone (TSH)	<1%	88,835	$835K
70496		<1%	4,680	$803K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	13,189	$799K
76830	Ultrasound, transvaginal	<1%	8,932	$769K
Q5115	Injection, rituximab-abbs, biosimilar, (truxima), 10 mg	<1%	264	$762K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	734	$711K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	9,071	$689K
87086	Culture, bacterial; quantitative colony count, urine	<1%	157,039	$625K
80061	Lipid panel	<1%	92,747	$603K
J2505	Injection, pegfilgrastim, 6 mg	<1%	373	$597K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	10,489	$596K
10060		<1%	3,366	$590K
93971		<1%	6,148	$537K
76801		<1%	10,382	$532K
87070		<1%	97,382	$525K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	2,215	$507K
78815	Positron emission tomography (PET) for limited area imaging	<1%	968	$504K
47562		<1%	222	$487K
76819	Fetal biophysical profile; without non-stress testing	<1%	9,322	$472K
58661		<1%	172	$457K
83036	Hemoglobin; glycosylated (A1C)	<1%	88,059	$449K
42830		<1%	250	$429K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	4,337	$403K
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	<1%	446	$384K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	6,169	$379K
12001		<1%	2,155	$376K
95813		<1%	1,330	$368K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	1,566	$362K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	23,851	$354K
64615		<1%	1,543	$354K
96416		<1%	1,549	$353K
70491		<1%	2,628	$347K
80048	Basic metabolic panel (calcium, ionized)	<1%	65,681	$334K
93970		<1%	3,232	$301K
71046	Radiologic examination, chest; 2 views	<1%	43,628	$293K
82728		<1%	42,662	$286K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	40,957	$279K
84484		<1%	65,561	$279K
96367		<1%	5,190	$276K
77336		<1%	4,861	$265K
86780		<1%	29,108	$259K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	1,651	$257K
80050	General health panel	<1%	32,236	$250K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	841	$244K
29581		<1%	1,872	$242K
J9312	Injection, rituximab, 10 mg	<1%	105	$242K
G0378	Hospital observation service, per hour	<1%	17,954	$241K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	3,489	$237K
95800		<1%	1,162	$237K
64405		<1%	1,186	$231K
83880		<1%	27,392	$230K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	97,439	$230K
36430		<1%	3,059	$230K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	49,988	$229K
58571		<1%	76	$225K
J1950	Injection, leuprolide acetate (for depot suspension), per 3.75 mg	<1%	379	$224K
J1453	Injection, fosaprepitant, 1 mg	<1%	2,149	$218K
87186		<1%	46,585	$216K
76770		<1%	2,443	$214K
87505		<1%	4,984	$202K
87205		<1%	78,221	$202K
84702		<1%	35,174	$200K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	18,375	$198K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	7,135	$196K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	638	$188K
86803		<1%	37,827	$186K
87808		<1%	44,576	$185K
82607		<1%	27,028	$184K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	15,048	$181K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	1,153	$177K
12002		<1%	1,079	$174K
J0897	Injection, denosumab, 1 mg	<1%	1,624	$170K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	1,450	$168K
84439		<1%	28,449	$168K
73630		<1%	12,208	$167K
83970		<1%	8,662	$166K
64400		<1%	596	$165K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	3,763	$161K
12011		<1%	999	$160K
76536		<1%	1,929	$159K
87529		<1%	8,888	$158K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,342	$157K
49083		<1%	492	$152K
76870		<1%	1,959	$152K
83605		<1%	28,573	$151K
86003		<1%	21,361	$150K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	17,318	$149K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	369	$148K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	11,292	$147K
83550		<1%	37,472	$146K
87481		<1%	17,720	$145K
77334		<1%	1,483	$143K
72125	Computed tomography, cervical spine; without contrast material	<1%	8,164	$142K
82570		<1%	33,068	$141K
86140		<1%	37,326	$140K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	1,598	$140K
70498		<1%	4,932	$139K
95806		<1%	267	$139K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	882	$134K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	5,811	$133K
86480		<1%	7,373	$132K
J1756	Injection, iron sucrose, 1 mg	<1%	7,187	$128K
71250		<1%	2,679	$128K
64450		<1%	489	$128K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	90,588	$126K
87400		<1%	12,454	$126K
J0185	Injection, aprepitant, 1 mg	<1%	1,599	$124K
76937		<1%	3,573	$122K
96523		<1%	3,432	$122K
87040		<1%	18,698	$121K
70487		<1%	747	$120K
36561		<1%	111	$118K
86235		<1%	12,921	$115K
85027		<1%	30,579	$115K
84403		<1%	9,776	$114K
83540		<1%	39,386	$114K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	40,737	$112K
70486		<1%	3,785	$111K
58670		<1%	45	$108K
73610		<1%	8,705	$100K
29125		<1%	880	$100K
77301		<1%	223	$96K
82784		<1%	13,063	$96K
82785		<1%	7,938	$96K
80055		<1%	16,222	$95K
77295		<1%	248	$92K
72100		<1%	7,054	$91K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	2,816	$90K
87149		<1%	15,594	$88K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	11,839	$87K
90715		<1%	4,909	$87K
74018		<1%	3,742	$86K
83735		<1%	40,498	$84K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	397	$81K
82746		<1%	18,229	$80K
76820		<1%	2,945	$79K
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	<1%	154	$78K
82247		<1%	13,011	$78K
81229		<1%	324	$78K
84146		<1%	6,726	$78K
82670		<1%	5,392	$77K
77300		<1%	1,481	$77K
96375	Therapeutic injection; each additional sequential IV push	<1%	78,742	$77K
87077		<1%	27,254	$75K
73562		<1%	6,614	$75K
87510		<1%	5,770	$75K
85652		<1%	30,949	$74K
87340		<1%	19,531	$74K
86376		<1%	6,353	$72K
81001		<1%	88,526	$72K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	785	$70K
83001		<1%	7,633	$69K
99214	Doctor's office visit, returning patient (more involved)	<1%	869	$69K
72156		<1%	930	$68K
36592		<1%	70,134	$68K
72197		<1%	297	$68K
83655		<1%	4,888	$68K
85379		<1%	15,632	$67K
87522	Neg quan hep c or qual rna	<1%	3,904	$66K
86706		<1%	16,468	$65K
73030		<1%	7,564	$65K
77290		<1%	230	$65K
86665		<1%	6,513	$64K
86039		<1%	11,476	$63K
80076		<1%	13,584	$62K
86481		<1%	3,356	$61K
52356		<1%	44	$61K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	5,439	$60K
72193		<1%	310	$60K
86704		<1%	12,710	$60K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	1,166	$58K
82950		<1%	16,842	$58K
82105		<1%	5,532	$57K
58662		<1%	27	$56K
87660		<1%	5,770	$56K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	2,758	$56K
73130		<1%	6,953	$56K
84703		<1%	49,989	$54K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	<1%	657	$53K
95811		<1%	156	$53K
72141		<1%	573	$53K
74175		<1%	319	$51K
86695		<1%	5,731	$51K
74174		<1%	296	$51K
97803		<1%	1,294	$51K
73110		<1%	5,251	$50K
83013		<1%	2,579	$50K
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	<1%	115	$49K
83690		<1%	50,391	$48K
44970		<1%	13	$47K
76813		<1%	1,246	$47K
Q3014	Telehealth originating site facility fee	<1%	2,201	$46K
80074		<1%	5,645	$46K
86696		<1%	6,770	$46K
83002		<1%	4,995	$46K
84156		<1%	16,489	$45K
81003		<1%	65,982	$45K
73502		<1%	4,505	$44K
J9310	Injection, rituximab, 100 mg	<1%	19	$44K
87081		<1%	15,239	$44K
80143		<1%	12,410	$44K
83993		<1%	3,370	$44K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	18,848	$43K
86256		<1%	6,267	$43K
82677		<1%	2,070	$43K
82043		<1%	18,025	$43K
95913		<1%	296	$42K
72131		<1%	1,559	$42K
86800		<1%	3,604	$42K
87631		<1%	1,508	$41K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	3,338	$41K
97597		<1%	811	$41K
86364		<1%	5,419	$41K
84153		<1%	6,354	$40K
83520		<1%	5,929	$39K
J2357	Injection, omalizumab, 5 mg	<1%	80	$39K
87480		<1%	5,770	$39K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	9,689	$39K
67311		<1%	13	$39K
71045	Radiologic examination, chest; single view	<1%	32,816	$38K
82248		<1%	9,073	$37K
0001A		<1%	1,179	$37K
73560		<1%	4,432	$37K
36591		<1%	8,350	$36K
84481		<1%	6,630	$36K
E0604	Breast pump, hospital grade, electric (ac and / or dc), any type	<1%	1,154	$36K
88307		<1%	2,064	$35K
84550		<1%	23,540	$35K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	609	$35K
83516		<1%	5,617	$35K
82330		<1%	9,325	$34K
82533		<1%	4,513	$34K
0002A		<1%	857	$34K
84145		<1%	3,502	$33K
80164		<1%	3,832	$33K
77338		<1%	292	$32K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	898	$32K
96368		<1%	3,008	$32K
J1447	Injection, tbo-filgrastim, 1 microgram	<1%	188	$32K
84270		<1%	3,226	$32K
73140		<1%	2,755	$31K
97802		<1%	487	$31K
10061		<1%	213	$31K
86787		<1%	5,763	$31K
84144		<1%	2,864	$30K
72040		<1%	1,845	$30K
72158		<1%	222	$29K
85610		<1%	50,407	$28K
96417		<1%	5,458	$28K
74183		<1%	146	$28K
64721		<1%	52	$28K
83883		<1%	3,395	$28K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	730	$27K
86762		<1%	4,086	$27K
82951		<1%	3,304	$27K
73221		<1%	186	$27K
83615		<1%	20,264	$27K
83525		<1%	2,928	$26K
82550		<1%	14,400	$26K
99152		<1%	4,810	$26K
73701		<1%	161	$26K
J9202	Goserelin acetate implant, per 3.6 mg	<1%	110	$26K
86160		<1%	6,669	$25K
95886		<1%	1,218	$25K
J3490	Unclassified drugs	<1%	1,099	$25K
99153	Mod sedat endo service >5yrs	<1%	4,065	$25K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	611	$24K
97162		<1%	736	$24K
86431		<1%	5,718	$24K
J2704	Injection, propofol, 10 mg	<1%	24,777	$24K
99213	Doctor's office visit, returning patient (routine)	<1%	386	$24K
58558		<1%	25	$24K
84100		<1%	12,970	$24K
80178		<1%	2,845	$24K
87430		<1%	8,687	$24K
85014		<1%	7,129	$23K
73080		<1%	1,911	$23K
84165		<1%	6,020	$23K
87209		<1%	3,216	$23K
97161		<1%	690	$22K
86334		<1%	3,809	$22K
80179		<1%	12,360	$22K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	56,829	$22K
73590		<1%	3,693	$22K
87493		<1%	2,729	$22K
80177		<1%	2,438	$22K
80069		<1%	3,320	$22K
J9201	Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg	<1%	136	$21K
86225		<1%	4,497	$21K
D2393	Resin-based composite - three surfaces, posterior, primary or permanent	<1%	12	$20K
87338		<1%	2,955	$20K
86200		<1%	3,888	$20K
86850		<1%	10,981	$20K
82627		<1%	2,039	$19K
D2930	Prefabricated stainless steel crown - primary tooth	<1%	22	$19K
80197		<1%	2,046	$19K
88342		<1%	2,270	$19K
76642		<1%	205	$19K
73700		<1%	264	$19K
64483		<1%	48	$18K
84480		<1%	2,689	$18K
82378		<1%	4,793	$18K
86304		<1%	2,057	$18K
83020		<1%	2,162	$18K
86812		<1%	1,461	$18K
86147		<1%	2,064	$18K
84410		<1%	998	$18K
A4649	Surgical supply; miscellaneous	<1%	7,391	$18K
86308		<1%	3,967	$17K
71101		<1%	2,578	$17K
73090		<1%	2,265	$17K
86708		<1%	2,848	$17K
73120		<1%	655	$17K
J3489	Injection, zoledronic acid, 1 mg	<1%	1,152	$17K
71271		<1%	189	$17K
J9206	Injection, irinotecan, 20 mg	<1%	170	$17K
69209		<1%	180	$16K
72157		<1%	240	$16K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	1,065	$16K
86923		<1%	2,108	$16K
87641		<1%	1,019	$15K
72072		<1%	825	$15K
86900		<1%	11,963	$15K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	524	$15K
86008		<1%	2,114	$15K
82565		<1%	7,703	$15K
81025		<1%	23,083	$14K
86301		<1%	1,534	$14K
84134		<1%	1,817	$14K
Q5102	Injection, infliximab, biosimilar, 10 mg	<1%	16	$14K
87177		<1%	3,218	$14K
73552		<1%	1,622	$14K
85730		<1%	13,816	$14K
J9070	Cyclophosphamide, 100 mg	<1%	176	$14K
80175		<1%	1,675	$14K
86677		<1%	1,225	$14K
86870		<1%	1,383	$13K
75574		<1%	70	$13K
84445		<1%	623	$13K
88304		<1%	3,323	$13K
84432		<1%	919	$13K
85018		<1%	6,221	$13K
95812		<1%	45	$13K
83014		<1%	2,576	$13K
88185		<1%	516	$13K
87634		<1%	556	$13K
82232		<1%	1,269	$13K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	29,802	$13K
84425		<1%	2,294	$12K
78306		<1%	66	$12K
99195		<1%	369	$12K
82274		<1%	2,767	$12K
87517		<1%	808	$12K
83721		<1%	2,358	$12K
85651		<1%	4,040	$12K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	39	$12K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	6,722	$12K
82952		<1%	3,230	$12K
70544		<1%	149	$12K
82977		<1%	6,869	$12K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	104	$11K
73660		<1%	949	$11K
86146		<1%	1,417	$11K
82947		<1%	7,739	$11K
96376		<1%	20,597	$11K
84305		<1%	870	$11K
83498		<1%	907	$11K
97166		<1%	341	$11K
84450		<1%	7,797	$11K
84163		<1%	977	$11K
86300		<1%	1,494	$11K
86756		<1%	3,082	$10K
0012A		<1%	270	$10K
20610		<1%	54	$10K
82150		<1%	6,415	$10K
87184		<1%	3,789	$10K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	49,205	$10K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	439	$10K
77001		<1%	302	$10K
29515		<1%	175	$10K
86901		<1%	13,027	$9K
86336		<1%	2,109	$9K
86694		<1%	745	$9K
84460		<1%	8,093	$9K
87046		<1%	1,688	$9K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	72,758	$9K
0011A		<1%	328	$9K
87328		<1%	1,783	$9K
36416		<1%	31,618	$9K
87210		<1%	1,976	$9K
82542		<1%	1,019	$9K
72128		<1%	566	$8K
72170		<1%	1,964	$8K
82040		<1%	6,417	$8K
90686		<1%	713	$7K
74178		<1%	51	$7K
80203		<1%	933	$7K
87536		<1%	117	$7K
81015		<1%	2,885	$7K
84166		<1%	974	$7K
88341		<1%	1,268	$7K
85045		<1%	3,909	$7K
82465		<1%	3,119	$7K
36590		<1%	12	$7K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	27	$7K
97165		<1%	182	$7K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	257	$7K
72070		<1%	1,012	$7K
96402		<1%	2,301	$7K
81050		<1%	3,005	$6K
43235		<1%	12	$6K
81241		<1%	278	$6K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	222	$6K
77387		<1%	2,375	$6K
82239		<1%	686	$6K
A9585	Injection, gadobutrol, 0.1 ml	<1%	2,342	$6K
93798		<1%	1,042	$6K
93017		<1%	62	$6K
95911		<1%	39	$6K
87593		<1%	72	$6K
82962		<1%	16,893	$6K
62323		<1%	12	$6K
87625		<1%	734	$6K
84155		<1%	6,118	$6K
83521		<1%	1,743	$6K
84681		<1%	658	$6K
86880		<1%	2,086	$6K
84478		<1%	1,915	$6K
82652		<1%	442	$6K
82103		<1%	688	$6K
36569		<1%	14	$6K
82390		<1%	865	$6K
20553		<1%	67	$6K
85613		<1%	1,116	$5K
87329		<1%	1,755	$5K
96040		<1%	680	$5K
88112		<1%	667	$5K
86920		<1%	914	$5K
82140		<1%	1,271	$5K
82310		<1%	2,796	$5K
87632		<1%	48	$5K
16020		<1%	41	$5K
77470		<1%	29	$5K
86735		<1%	1,301	$5K
87420		<1%	342	$5K
82024		<1%	648	$5K
J1170	Injection, hydromorphone, up to 4 mg	<1%	18,363	$5K
C1769	Guide wire	<1%	5,001	$5K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	535	$5K
85240		<1%	1,087	$5K
83010		<1%	787	$5K
73070		<1%	1,451	$5K
86765		<1%	1,240	$5K
83090		<1%	355	$5K
77280		<1%	29	$5K
51798		<1%	1,274	$4K
73060		<1%	872	$4K
86592		<1%	1,538	$4K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	22,712	$4K
90674		<1%	369	$4K
77332		<1%	78	$4K
96401		<1%	1,438	$4K
0031A		<1%	111	$4K
86769		<1%	776	$4K
82731		<1%	192	$4K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	828	$4K
D7140	Extraction, erupted tooth or exposed root	<1%	12	$4K
82525		<1%	386	$4K
74022		<1%	399	$4K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	1,891	$4K
80159		<1%	506	$4K
80183		<1%	376	$4K
73564		<1%	174	$4K
94010		<1%	211	$4K
59020		<1%	40	$4K
84630		<1%	433	$4K
99215	Doctor's office visit, returning patient (complex)	<1%	61	$4K
72050		<1%	131	$3K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	34,834	$3K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	37,423	$3K
96411		<1%	3,170	$3K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	4,369	$3K
82668		<1%	561	$3K
10005		<1%	13	$3K
87902		<1%	161	$3K
D2392	Resin-based composite - two surfaces, posterior, primary or permanent	<1%	12	$3K
88173		<1%	250	$3K
88360		<1%	202	$3K
86360		<1%	234	$3K
81240		<1%	256	$3K
77063	Screening digital breast tomosynthesis, bilateral	<1%	1,166	$3K
77080		<1%	60	$3K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	4,663	$3K
76942		<1%	41	$3K
88184		<1%	483	$3K
80051		<1%	4,075	$3K
83021		<1%	673	$3K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	15,471	$3K
85007		<1%	2,751	$3K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	26,672	$3K
82077		<1%	14,929	$3K
G0145	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision	<1%	173	$3K
77066	Tomosynthesis, mammo	<1%	87	$3K
81596		<1%	98	$3K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	8,312	$3K
81243		<1%	72	$3K
82270		<1%	2,093	$2K
C1760	Closure device, vascular (implantable/insertable)	<1%	1,652	$2K
82010		<1%	3,780	$2K
10160		<1%	25	$2K
99203	Doctor's office visit, new patient (routine)	<1%	30	$2K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	22,294	$2K
86036		<1%	473	$2K
86141		<1%	411	$2K
J2060	Injection, lorazepam, 2 mg	<1%	7,362	$2K
84520		<1%	4,632	$2K
82553		<1%	247	$2K
J9267	Injection, paclitaxel, 1 mg	<1%	2,668	$2K
82681		<1%	223	$2K
86778		<1%	206	$2K
86341		<1%	260	$2K
86593		<1%	844	$2K
87075		<1%	690	$2K
99204	Doctor's office visit, new patient (more involved)	<1%	15	$2K
84466		<1%	396	$2K
J0690	Injection, cefazolin sodium, 500 mg	<1%	15,074	$2K
J8540	Dexamethasone, oral, 0.25 mg	<1%	5,268	$2K
84132		<1%	1,484	$2K
91065		<1%	86	$2K
J0500	Injection, dicyclomine hcl, up to 20 mg	<1%	1,070	$2K
92567		<1%	212	$2K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	28,015	$2K
92610		<1%	54	$1K
J9190	Injection, fluorouracil, 500 mg	<1%	6,226	$1K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	16,960	$1K
80299		<1%	263	$1K
84436		<1%	189	$1K
87045		<1%	241	$1K
87101		<1%	242	$1K
87102		<1%	535	$1K
84075		<1%	4,282	$1K
70549		<1%	15	$1K
86645		<1%	126	$1K
83718		<1%	115	$1K
J2997	Injection, alteplase recombinant, 1 mg	<1%	34	$1K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	41	$1K
86777		<1%	208	$1K
73000		<1%	109	$1K
99151		<1%	15	$1K
85048		<1%	179	$1K
80185		<1%	120	$1K
74019		<1%	26	$1K
41800		<1%	14	$1K
C1781	Mesh (implantable)	<1%	260	$1K
77333		<1%	14	$1K
76857		<1%	29	$1K
D3220	Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction	<1%	17	$1K
93797		<1%	307	$1K
86644		<1%	116	$1K
85390		<1%	490	$988.99
84590		<1%	162	$987.33
89055		<1%	602	$934.46
87427		<1%	237	$921.93
77002		<1%	12	$892.80
70360		<1%	92	$881.19
87449		<1%	153	$881.00
85246		<1%	170	$869.53
82805		<1%	1,551	$869.09
72220		<1%	101	$852.62
J3370	Injection, vancomycin hcl, 500 mg	<1%	4,633	$842.70
85245		<1%	124	$833.12
86359		<1%	207	$825.37
93923		<1%	12	$804.78
J1940	Injection, furosemide, up to 20 mg	<1%	2,958	$803.83
96409		<1%	72	$772.20
C1776	Joint device (implantable)	<1%	54	$756.43
87220		<1%	239	$749.41
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	6,624	$745.90
51702		<1%	191	$716.48
G0498	Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion	<1%	1,172	$710.35
85306		<1%	159	$700.02
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	<1%	3,623	$694.49
82365		<1%	164	$681.66
M0220	Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring	<1%	73	$666.62
J0780	Injection, prochlorperazine, up to 10 mg	<1%	3,292	$656.90
84235		<1%	29	$650.38
84181		<1%	94	$630.74
84402		<1%	50	$629.50
J9045	Injection, carboplatin, 50 mg	<1%	1,796	$606.14
90714		<1%	32	$587.83
80156		<1%	59	$584.30
G2215	Take-home supply of nasal naloxone; 2-pack of 4mg per 0.1 ml nasal spray (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure	<1%	56	$576.47
92582		<1%	13	$568.10
0225U		<1%	989	$550.26
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	50	$548.02
92524		<1%	13	$541.09
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	1,417	$534.37
77065	Tomosynthesis, mammo	<1%	17	$511.98
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	6,686	$509.24
C2617	Stent, non-coronary, temporary, without delivery system	<1%	170	$502.23
76802		<1%	14	$490.37
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	9,487	$489.69
J1630	Injection, haloperidol, up to 5 mg	<1%	3,496	$477.40
J3480	Injection, potassium chloride, per 2 meq	<1%	3,972	$469.27
85303		<1%	138	$469.06
A9577	Injection, gadobenate dimeglumine (multihance), per ml	<1%	1,168	$458.92
95250		<1%	13	$453.55
76812		<1%	13	$446.60
84446		<1%	64	$435.64
85384		<1%	440	$422.72
J1650	Injection, enoxaparin sodium, 10 mg	<1%	6,619	$421.06
C1729	Catheter, drainage	<1%	2,490	$420.94
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	253	$417.32
86618		<1%	55	$409.81
89051		<1%	918	$401.14
73600		<1%	16	$370.90
J3360	Injection, diazepam, up to 5 mg	<1%	1,229	$370.50
88300		<1%	28	$362.63
82626		<1%	29	$358.03
74220		<1%	12	$356.15
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	599	$349.90
C9113	Injection, pantoprazole sodium, per vial	<1%	902	$340.78
82164		<1%	46	$330.64
J1815	Injection, insulin, per 5 units	<1%	6,261	$328.05
92555		<1%	24	$326.92
36593		<1%	12	$324.77
86352		<1%	12	$324.27
73521		<1%	12	$320.84
81270		<1%	15	$319.80
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	1,879	$314.51
J1644	Injection, heparin sodium, per 1000 units	<1%	9,819	$306.92
82672		<1%	25	$303.65
97760		<1%	18	$299.70
J1790	Injection, droperidol, up to 5 mg	<1%	1,587	$282.62
76380		<1%	12	$280.04
80202		<1%	27	$271.42
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	382	$267.80
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	26	$266.31
84112		<1%	183	$257.71
85300		<1%	100	$251.37
89125		<1%	78	$250.85
0003A		<1%	12	$243.20
84207		<1%	49	$235.69
72192		<1%	12	$235.01
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	126	$234.71
88142		<1%	14	$231.78
80305		<1%	1,614	$218.64
84244		<1%	24	$214.70
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	359	$205.25
87116		<1%	15	$195.14
87140		<1%	15	$192.30
83519		<1%	36	$188.78
80162		<1%	17	$184.48
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	749	$179.12
81256		<1%	15	$177.96
J3475	Injection, magnesium sulfate, per 500 mg	<1%	4,323	$171.80
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	2,297	$164.28
C9399	Unclassified drugs or biologicals	<1%	286	$162.80
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	2,014	$162.71
82803		<1%	3,492	$160.86
J2550	Injection, promethazine hcl, up to 50 mg	<1%	920	$132.64
85660		<1%	78	$124.50
90656		<1%	13	$117.80
82085		<1%	37	$111.82
J0461	Injection, atropine sulfate, 0.01 mg	<1%	588	$109.30
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	<1%	128	$104.52
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	2,715	$101.43
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	65	$100.14
86335		<1%	27	$99.70
87341		<1%	24	$88.89
92587		<1%	13	$82.56
C9463	Injection, aprepitant, 1 mg	<1%	194	$79.01
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	601	$71.11
85347		<1%	560	$69.83
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	6,101	$69.45
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	538	$67.61
87110		<1%	15	$66.20
J3411	Injection, thiamine hcl, 100 mg	<1%	805	$62.03
85307		<1%	13	$61.26
99173		<1%	31	$58.00
86922		<1%	23	$57.30
C1758	Catheter, ureteral	<1%	547	$53.05
87425		<1%	13	$52.43
88302		<1%	110	$52.39
C2625	Stent, non-coronary, temporary, with delivery system	<1%	220	$51.63
87015		<1%	15	$41.81
84300		<1%	12	$40.11
87206		<1%	16	$35.53
90662		<1%	114	$31.52
G0472	Hepatitis c antibody screening, for individual at high risk and other covered indication(s)	<1%	620	$30.47
J1956	Injection, levofloxacin, 250 mg	<1%	757	$28.32
A4314	Insertion tray with drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.)	<1%	1,715	$28.10
86162		<1%	14	$26.88
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	1,291	$22.91
87088		<1%	422	$13.36
83930		<1%	14	$13.29
90694		<1%	26	$13.08
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	<1%	14	$11.61
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	2,148	$10.02
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	302	$6.44
J0456	Injection, azithromycin, 500 mg	<1%	303	$5.12
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	529	$4.63
J1836	Injection, metronidazole, 10 mg	<1%	533	$3.56
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	910	$3.16
87905		<1%	252	$2.28
J2470	Injection, pantoprazole sodium, 40 mg	<1%	119	$2.20
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	20	$1.88
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	1,024	$1.01
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, or silicone elastomer, etc.), each	<1%	706	$0.82
S2900	Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure)	<1%	120	$0.76
Q9969	Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose	<1%	531	$0.46
84157		<1%	12	$0.44
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	234	$0.29
Q0220	Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg	<1%	83	$0.28
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	0%	766	$0.00
J9060	Injection, cisplatin, powder or solution, 10 mg	0%	176	$0.00
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	0%	20	$0.00
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	0%	25,496	$0.00
J2720	Injection, protamine sulfate, per 10 mg	0%	37	$0.00
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate)	0%	51	$0.00
J1953	Injection, levetiracetam, 10 mg	0%	124	$0.00
A4358	Urinary drainage bag, leg or abdomen, vinyl, with or without tube, with straps, each	0%	67	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	437	$0.00
D1120	Dental cleaning, child	0%	34	$0.00
77062		0%	85	$0.00
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	0%	168	$0.00
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	0%	125	$0.00
J0737	Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg	0%	134	$0.00
C1788	Port, indwelling (implantable)	0%	151	$0.00
J3473	Injection, hyaluronidase, recombinant, 1 usp unit	0%	12	$0.00
91300		0%	1,837	$0.00
A9537	Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries	0%	12	$0.00
J0688	Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg	0%	12	$0.00
J3371	Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg	0%	41	$0.00
D0220	Intraoral - periapical first radiographic image	0%	18	$0.00
G0008	Administration of influenza virus vaccine	0%	169	$0.00
A4338	Indwelling catheter; foley type, two-way latex with coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	0%	230	$0.00
C1726	Catheter, balloon dilatation, non-vascular	0%	122	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	693	$0.00
J0173	Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg	0%	239	$0.00
J2305	Injection, nitroglycerin, 5 mg	0%	25	$0.00
J9181	Injection, etoposide, 10 mg	0%	56	$0.00
91301		0%	578	$0.00
D0230	Intraoral - periapical each additional radiographic image	0%	18	$0.00
J7999	Compounded drug, not otherwise classified	0%	13	$0.00
G0475	Hiv antigen/antibody, combination assay, screening	0%	20	$0.00
96521		0%	65	$0.00
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	0%	27	$0.00
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	0%	76	$0.00
J2560	Injection, phenobarbital sodium, up to 120 mg	0%	34	$0.00
J2785	Injection, regadenoson, 0.1 mg	0%	25	$0.00
C1766	Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away	0%	13	$0.00
C1732	Catheter, electrophysiology, diagnostic/ablation, 3d or vector mapping	0%	32	$0.00
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	0%	17	$0.00
D1208	Topical application of fluoride, excluding varnish	0%	20	$0.00
81511		0%	12	$0.00
A4590	Special casting material (e.g., fiberglass)	0%	12	$0.00
J1030	Injection, methylprednisolone acetate, 40 mg	0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialROBERTSON, WILLIAM (CEO)

Same official

Other billing entities under ROBERTSON, WILLIAM

Full network →

Provider	Location	Paid
Multicare Health System	Tacoma, WA	$108.54M
Yakima Valley Memorial Hospital Association	Yakima, WA	$103.54M
Multicare Health System	Puyallup, WA	$77.99M
Multicare Health System	Tacoma, WA	$75.17M
Greater Lakes Mental Health Foundation INC	Lakewood, WA	$55.95M
Multicare Health System	Spokane, WA	$55.23M
Multicare Health System	Auburn, WA	$31.02M
Multicare Health System	Spokane Valley, WA	$24.75M
Multicare Health System	Covington, WA	$23.19M
Multicare Health System	Olympia, WA	$16.97M
Multicare Health System	Tacoma, WA	$11.14M
Multicare Health System	Auburn, WA	$7.42M
Multicare Health System	Tacoma, WA	$2.68M
Alliance for South Sound Health	Tacoma, WA	$2.46M
Capital Medical Center Physicians LLC	Olympia, WA	$1.75M
Multicare Health System	Tacoma, WA	$1.53M
Yakima Valley Memorial Hospital Association	Yakima, WA	$1.16M
Capital Medical Center Specialty Physicians, LLC	Olympia, WA	$987K
Yakima Urology at Memorial TR	Yakima, WA	$784K
Multicare Health System	Spokane, WA	$179K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.